M Yoshimura

727 total citations
24 papers, 561 citations indexed

About

M Yoshimura is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, M Yoshimura has authored 24 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in M Yoshimura's work include Muscle Physiology and Disorders (6 papers), Virus-based gene therapy research (5 papers) and Fungal Biology and Applications (3 papers). M Yoshimura is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Virus-based gene therapy research (5 papers) and Fungal Biology and Applications (3 papers). M Yoshimura collaborates with scholars based in Japan, United States and Australia. M Yoshimura's co-authors include Shin’ichi Takeda, Katsutoshi Yuasa, Yuko Miyagoe‐Suzuki, Miki Sakamoto, Akinori Nakamura, Nobuyuki Urasawa, Madoka Ikemoto‐Uezumi, Yasushi Mochizuki, Norikazu Tamaoki and Yoshiki Shimatsu and has published in prestigious journals such as Food Chemistry, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

M Yoshimura

24 papers receiving 551 citations

Peers

M Yoshimura
Eleanor Hilliard United States
Xiaohuan Gao United States
Hong-Jin Shu United States
Bo Dai China
Cathy J. Hatcher United States
Woong Hahn South Korea
Nand Relan United States
M Yoshimura
Citations per year, relative to M Yoshimura M Yoshimura (= 1×) peers Joachim Stjernvall

Countries citing papers authored by M Yoshimura

Since Specialization
Citations

This map shows the geographic impact of M Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Yoshimura more than expected).

Fields of papers citing papers by M Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Yoshimura. The network helps show where M Yoshimura may publish in the future.

Co-authorship network of co-authors of M Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of M Yoshimura. A scholar is included among the top collaborators of M Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Yoshimura. M Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshimura, M, et al.. (2025). Protein-tannins binding mode in hydrolyzable tannins-induced protein aggregation. Food Chemistry. 493(Pt 1). 145672–145672. 1 indexed citations
2.
3.
Jassem, Jacek, M Yoshimura, Francovito Piantedosi, et al.. (2010). MAGE-A3 GENE EXPRESSION FREQUENCY AND DEMOGRAPHY DATA OF STAGE IB-IIIA NSCLC PATIENTS FROM ONGOING MAGRIT PHASE III TRIAL EVALUATING MAGE-A3 ANTIGEN SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT TREATMENT. Annals of Oncology. 21. 134–134. 6 indexed citations
4.
Yoshimura, M, Akinori Nakamura, Miwa Kobayashi, & Shin’ichi Takeda. (2007). G.P.1.13 Deflazacort induced severe skeletal muscle wasting and inguinal herniation in normal Beagle dogs. Neuromuscular Disorders. 17(9-10). 775–775. 1 indexed citations
5.
Yuasa, Katsutoshi, M Yoshimura, Nobuyuki Urasawa, et al.. (2007). Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Therapy. 14(17). 1249–1260. 82 indexed citations
6.
Urasawa, Nobuyuki, Yoko Fujii, M Yoshimura, et al.. (2006). Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies. BMC Cardiovascular Disorders. 6(1). 47–47. 47 indexed citations
7.
Shimatsu, Yoshiki, M Yoshimura, Katsutoshi Yuasa, et al.. (2005). Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.. PubMed. 24(2). 145–54. 68 indexed citations
8.
Yoshimura, M, Miki Sakamoto, Madoka Ikemoto‐Uezumi, et al.. (2004). AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Molecular Therapy. 10(5). 821–828. 91 indexed citations
9.
Sakamoto, Miki, Katsutoshi Yuasa, M Yoshimura, et al.. (2002). Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochemical and Biophysical Research Communications. 293(4). 1265–1272. 89 indexed citations
11.
Abe, Yoshiyuki, Yoshihisa Ohnishi, M Yoshimura, et al.. (1996). P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. British Journal of Cancer. 74(12). 1929–1934. 26 indexed citations
12.
Tokuda, Yutaka, Yasuyuki Ohnishi, Kunihiro Shimamura, et al.. (1996). In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product. British Journal of Cancer. 73(11). 1362–1365. 60 indexed citations
13.
Ohnishi, Yasuyuki, Hiroyuki Nakamura, M Yoshimura, et al.. (1995). Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody. British Journal of Cancer. 71(5). 969–973. 26 indexed citations
14.
Saito, Kazuki, Keiko Matsunaga, Yusuke Oguchi, et al.. (1994). Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line.. PubMed. 8(2). 241–5. 6 indexed citations
15.
Maniwa, Yoshimasa, Noriaki Tsubota, M Yoshimura, et al.. (1994). [A case of the localized fibrous mesothelioma which size decreased temporarily].. PubMed. 47(11). 948–51. 1 indexed citations
16.
Matsunaga, Kenichi, Hiroko Iijima, Hiroaki Endo, et al.. (1992). Effects of Biological Response Modifiers with Different Modes of Action Used Separately and Together on Immune Responses in Mice with Syngeneic Tumours. Journal of International Medical Research. 20(5). 406–421. 4 indexed citations
17.
Maeshima, Shinichiro, et al.. (1992). ["Left unilateral agraphia with right hemiparesis" after occlusion of the left middle cerebral artery].. PubMed. 44(7). 661–6. 2 indexed citations
18.
Yoshimura, M, et al.. (1988). [Reconstruction of the collapsed lung].. PubMed. 36(12). 2667–72. 2 indexed citations
19.
Yoshimura, M, Hiroshi Kida, Yuki Saito, et al.. (1985). Peculiar glomerular lesions in Takayasu's arteritis.. PubMed. 24(3). 120–7. 27 indexed citations
20.
Yoshimura, M, Hiroshi Kida, Shin’ichi Takeda, et al.. (1984). [Renal lesions in aortitis syndrome (Takayasu's arteritis)].. PubMed. 26(11). 1565–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026